These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8274414)

  • 1. Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxemia with long-term oxygen therapy.
    Aasebø U; Gyltnes A; Bremnes RM; Aakvaag A; Slørdal L
    J Steroid Biochem Mol Biol; 1993 Dec; 46(6):799-803. PubMed ID: 8274414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin and sexual dysfunction.
    Lawrence IG; Price DE; Howlett TA; Harris KP; Feehally J; Walls J
    Nephrol Dial Transplant; 1997 Apr; 12(4):741-7. PubMed ID: 9141005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impotence of endocrine origin with normal blood testosterone levels].
    Kuhn JM; Grise P; Weber J; Wolf LM
    Acta Urol Belg; 1988; 56(2):162-5. PubMed ID: 3135705
    [No Abstract]   [Full Text] [Related]  

  • 4. Sexual dysfunction and erectile impotence in chronic obstructive pulmonary disease.
    Fletcher EC; Martin RJ
    Chest; 1982 Apr; 81(4):413-21. PubMed ID: 6802573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteinizing release hormone tests in impotent diabetic males.
    Wright AD; London DR; Holder G; Williams JW; Rudd BT
    Diabetes; 1976 Oct; 25(10):975-7. PubMed ID: 789159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex hormone suppression and sexual impotence in hypoxic pulmonary fibrosis.
    Semple PD; Beastall GH; Brown TM; Stirling KW; Mills RJ; Watson WS
    Thorax; 1984 Jan; 39(1):46-51. PubMed ID: 6695352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of hypoxaemia on neuroendocrine function and catecholamine secretion in chronic obstructive pulmonary disease (COPD). Effects of long-term oxygen treatment.
    Bratel T; Wennlund A; Carlström K
    Respir Med; 2000 Dec; 94(12):1221-8. PubMed ID: 11192959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual dysfunctions and blood hormonal profile in men with focal epilepsy.
    Kuba R; Pohanka M; Zákopcan J; Novotná I; Rektor I
    Epilepsia; 2006 Dec; 47(12):2135-40. PubMed ID: 17201714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of uraemic impotence by zinc.
    Antoniou LD; Shalhoub RJ; Sudhakar T; Smith JC
    Lancet; 1977 Oct; 2(8044):895-8. PubMed ID: 72240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteinizing hormone, follicle stimulating hormone and testosterone in normal and impotent men following LHRH and HCG stimulation.
    Delitala G; Masala A; Alagna S; Lotti G
    Clin Endocrinol (Oxf); 1977 Jan; 6(1):11-15. PubMed ID: 321154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine assessment of impotence--pitfalls of measuring serum testosterone without sex-hormone-binding globulin.
    Hardy KJ; Seckl JR
    Postgrad Med J; 1994 Nov; 70(829):836-7. PubMed ID: 7824423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinaemia and impotence.
    Franks S; Jacobs HS; Martin N; Nabarro JD
    Clin Endocrinol (Oxf); 1978 Apr; 8(4):277-87. PubMed ID: 647983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the endocrine manifestations of hepatic cirrhosis.
    Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
    Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypogonadism in Rhodesian sleeping sickness: evidence for acute and chronic dysfunction of the hypothalamic-pituitary-gonadal axis.
    Petzke F; Heppner C; Mbulamberi D; Winkelmann W; Chrousos GP; Allolio B; Reincke M
    Fertil Steril; 1996 Jan; 65(1):68-75. PubMed ID: 8557157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erectile dysfunction and hypogonadism. Is routine endocrine screening necessary?].
    Noldus J; Huland H
    Urologe A; 1994 Jan; 33(1):73-5. PubMed ID: 8146936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and hormonal effects of testosterone undecanoate (TU) in male sexual impotence.
    Klepsch I; Măicănescu-Georgescu M; Marinescu L
    Endocrinologie; 1982; 20(4):289-93. PubMed ID: 6818673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced 'gonadotrophin response to releasing hormone' after chronic administration to impotent men.
    Davies TF; Gomez-Pan A; Watson MJ; Mountjoy CQ; Hanker JP; Besser GM; Hall R
    Clin Endocrinol (Oxf); 1977 Mar; 6(3):213-8. PubMed ID: 322894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex hormones and pituitary function in male epileptic patients with altered or normal sexuality.
    Murialdo G; Galimberti CA; Fonzi S; Manni R; Costelli P; Parodi C; Solinas GP; Amoretti G; Tartara A
    Epilepsia; 1995 Apr; 36(4):360-5. PubMed ID: 7607114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility.
    Fabbri A; Jannini EA; Ulisse S; Gnessi L; Moretti C; Frajese G; Isidori A
    J Clin Endocrinol Metab; 1988 Nov; 67(5):867-75. PubMed ID: 3141450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.